Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-027234
Filing Date
2024-03-28
Accepted
2024-03-28 16:16:01
Documents
66
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0202331-10k_raphael.htm   iXBRL 10-K 1377569
2 ENGLISH TRANSLATION OF THE AMENDMENT TO THE SERVICE AGREEMENT BY AND BETWEEN THE ea020233101ex10-4_raphael.htm EX-10.4 3336
3 CERTIFICATION ea020233101ex31-1_raphael.htm EX-31.1 10088
4 CERTIFICATION ea020233101ex31-2_raphael.htm EX-31.2 10016
5 CERTIFICATION ea020233101ex32-1_raphael.htm EX-32.1 3333
6 CERTIFICATION ea020233101ex32-2_raphael.htm EX-32.2 3334
7 GRAPHIC image_001.jpg GRAPHIC 11464
8 GRAPHIC image_002.jpg GRAPHIC 23465
9 GRAPHIC image_003.jpg GRAPHIC 2787
10 GRAPHIC image_004.jpg GRAPHIC 28561
  Complete submission text file 0001213900-24-027234.txt   4515164

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE raph-20231231.xsd EX-101.SCH 43991
12 XBRL CALCULATION FILE raph-20231231_cal.xml EX-101.CAL 28348
13 XBRL DEFINITION FILE raph-20231231_def.xml EX-101.DEF 160673
14 XBRL LABEL FILE raph-20231231_lab.xml EX-101.LAB 288315
15 XBRL PRESENTATION FILE raph-20231231_pre.xml EX-101.PRE 151632
70 EXTRACTED XBRL INSTANCE DOCUMENT ea0202331-10k_raphael_htm.xml XML 308422
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

EIN.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53002 | Film No.: 24799161
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)